Showing 201-210 of 501 results for "".
- Cutera, Inc. Appoints Jeff Jones as Chief Operating Officerhttps://modernaesthetics.com/news/cutera-inc-appoints-jeff-jones-as-chief-operating-officer/2473482/Jeff Jones is Cutera, Inc.’s new Chief Operating Officer, effective August 28, 2023. Mr. Jones will report directly to Taylor Harris, Cutera’s Chief Executive Officer, and will be responsible for end-to-end operations, including manufacturing, quality, supply chain, fi
- Calling all Applicants: Estée Lauder Companies New Incubation Ventures Launches 2023 BEAUTY&YOU India Programhttps://modernaesthetics.com/news/calling-all-applicants-estee-lauder-companies-new-incubation-ventures-launches-2023-beautyyou-india-program/2473469/The Estée Lauder Companies (ELC) is launching the second edition of BEAUTY&YOU. Created by ELC’s New Incubation Ventures and launched in partnership with India’s preferred beauty and lifestyle retailer, NYKAA, BEAUTY&YOU aims to continue its mission to di
- Estée Lauder, Manchester United Partner to Boost Fans’ Skin Healthhttps://modernaesthetics.com/news/estee-lauder-manchester-united-partner-to-boost-fans-skin-health/2473451/Estée Lauder will team up with Manchester United, to reach and engage their extensive fanbase in China and the Asia Pacific region. Kicking off in Summer 2023, the partnership’s inaugural campaign will launch with players from Manchester United’s first team, inc
- Exosome News: Elevai Labs Scores Grant to Better Characterize Stem Cell-derived Exosomeshttps://modernaesthetics.com/news/elevai-labs-scores-grant-to-better-characterize-stem-cell-derived-exosomes/2473403/Elevai Labs is partnering with Dr. Stanislav Sokolenko’s Lab at Dalhousie University in Nova Scotia, Canada to better characterize Elevai 's stem cell-derived exosomes thanks to a non-repayable grant from the Mitacs Accelerate Grants Program (“Mitacs”).
- Hydrafacial X Omorovicza Announce Launch of Advanced Skin Renewal Boosterhttps://modernaesthetics.com/news/hydrafacial-x-omorovicza-announce-launch-of-advanced-skin-renewal-booster/2473364/The Beauty Health Company’s Hydrafacial is rolling out a new booster co-created with Hungarian skincare brand Omorovicza. The booster, available immediately to Hydrafacial providers in North America and EMEA, leverages Omorovicza’s patented Healing Concentrate for a mo
- Industry Vet Crystal Muilenburg Joins Elevai’s Board of Directorshttps://modernaesthetics.com/news/industry-vet-crystal-muilenburg-joins-elevais-board-of-directors/2473357/Crystal Muilenburg is the newest member of Elevai’s Board of Directors. A former Evolus and Allergan executive, Muilenburg will play a key role in supporting the Elevai management team as it commercializes Elevai’s flagship exosome product line while driving t
- New Hydrafacial Booster Alert: DOCTOR BABOR Collagen HA Booster Now Availablehttps://modernaesthetics.com/news/new-hydrafacial-booster-alert-doctor-babor-collagen-ha-booster-now-available/2473337/The Beauty Health Company’s Hydrafacial launched a new booster co-created with BABOR Skincare. The new DOCTOR BABOR Collagen HA booster is inspired by DOCTOR BABOR’s formulations and developed with the BABOR Laboratories in Germany. “Hydrafacial has cre
- U.S. FDA Clears EndyMed’s Pure Laser Hair Removal Devicehttps://modernaesthetics.com/news/us-fda-clears-endymeds-pure-laser-hair-removal-device/2473318/The US Food and Drug Administration has cleared Endymed Ltd’s Pure Laser hair removal device for the marketing and sales. The Pure Laser was developed in the Company's labs by its subsidiary Endymed Medical Ltd. The Company intends to commence marketing in the US th
- FDA Grants 510(k)Clearance to LASEROPTEK's HELIOS IV-785 for Aesthetic and Medical Dermatology Usehttps://modernaesthetics.com/news/fda-grants-510kclearance-to-laseropteks-helios-iv-785-for-aesthetic-and-medical-dermatology-use/2473291/The U.S. Food and Drug Administration has granted 510(k) clearance to LASEROPTEK Co., Ltd.’s HELIOS IV-785 laser system for aesthetic and medical dermatology applications. HELIOS IV-785's novel and synergistic combination of 785nm picosecond photoacoustic effect and 1064 &
- Bausch Health Suspends Plans for Solta IPOhttps://modernaesthetics.com/news/bausch-health-suspends-plans-for-solta-ipo-1/2473255/Bausch Health Companies Inc. is suspending its plans for the Solta IPO due to challenging market conditions and other factors. Bausch Health stated that the interests of the Company's stakeholders are best served in the near-term by focusing on driving Solta's revenue, profits a